Epidermotropism &/or Pautrier microabscesses
•
Peripheral blood with multilobated “flower cells”
•
Lymph nodes with effaced architecture & diffuse infiltrate
•
Bone marrow with patchy involvement & increased osteoclasts
Ancillary Tests
•
Confirmation of HTLV-I infection by serology
Regulatory T cells CD3(+), CD4(+), CD25(+), FOXP3(+), CD194(+)
Often lose CD7 expression
Cytotoxic markers (-)
•
Clonal T-cell receptor gene rearrangement
•
Complex chromosomal abnormalities; no one abnormality is characteristic of ATLL
Top Differential Diagnoses
•
Mycosis fungoides
Similar clinical picture with epidermotropism & peripheral blood lymphocytosis
Also CD4(+), CD8(-) T cells, but CD25(-), FOXP3(-), & CD30(-)
•
Anaplastic large cell lymphoma
FOXP3(-), CD194(-); ALK1 & EMA(+/-), unlike ATLL
TERMINOLOGY
Abbreviations
•
Adult T-cell leukemia/lymphoma (ATLL)
Definitions
•
T-cell lymphoma/leukemia of regulatory T cells [CD4(+), CD25(+), FOXP3(+)] caused by human T-cell leukemia virus type I (HTLV-I)
ETIOLOGY/PATHOGENESIS
Infectious Agents
•
HTLV-I
Type C retrovirus, composed of single-stranded RNA, which is converted into double-strand DNA during infection
Virus is monoclonally integrated into host genome
Progresses to leukemia/lymphoma in < 5% of infected individuals
Long latency period
–
Most exposed as infants/children
–
Tumor often develops after 20 years of viral exposure
Transmitted through blood, sexual intercourse, or breast milk
HLA alleles A26, B4002, B4006, & B4801 may be predisposed to developing ATLL
Inflammatory diseases related to HTLV-I include tropical spastic paraparesis, HTLV-I-associated myelopathy, HTLV-I-associated uveitis, & infective dermatitis
Encodes tax (viral oncoprotein)
–
Plays role in development of ATLL
–
Activates transcription factors for T-cell proliferation genes
CLINICAL ISSUES
Epidemiology
•
Age
Adults; most commonly in 6th or 7th decades
•
Sex
M:F = 1.5:1.0
•
Ethnicity
Endemic to Southwest Japan, Caribbean, South America, Australia, & Central Africa
Presentation
•
Skin lesions
Develop in 50% of ATLL patients
Usually multiple nodules/tumors, papules, plaques, or macules
–
Papules may cover large segments of body
Rarely, erythroderma, purpura, prurigo, or erythema multiforme
•
Other sites of disease include lymph nodes, peripheral blood, bone, spleen & sometimes lung, liver, & CNS
Most patients have generalized lymphadenopathy
Hypercalcemia from increased osteoclast bone resorption
•
4 clinical subtypes of ATLL
Acute subtype
–
Most common subtype, 60%, often in children
–
Severe peripheral blood lymphocytosis, ↑ WBC, ↑ lactate dehydrogenase (LDH), skin lesions, lymphadenopathy
–
Hypercalcemia, lytic bone lesions, renal dysfunction, neuropsychiatric problems
–
Immunodeficiency leads to other opportunistic infections
Chronic subtype
–
Lymphocytosis but ↓ WBC than acute subtype
–
No hypercalcemia, exfoliative skin rash
Lymphomatous subtype
–
↑ lymphadenopathy; usually no peripheral blood involvement
–
Less hypercalcemia than acute subtype; skin often involved
Smoldering subtype
–
> 5% tumor cells in peripheral blood, even though normal WBC count
–
Tumor cells small with less pleomorphism & lobation
–
No hypercalcemia or lymphadenopathy
•
Skin lesions are mostly in acute & lymphomatous subtypes